Relationship of acquired resistance of myeloma cells to bortezomib with Lyn and Src induced inhibition of PP2A and effect of treatment with the tyrosine kinase inhibitor dasatinib.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke University, Duke Medical Center, Durham VA Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891807448
